XML 56 R47.htm IDEA: XBRL DOCUMENT v3.19.2
Stockholders' Equity (Deficit) (Details Textual) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended
Dec. 12, 2018
Nov. 30, 2018
Feb. 28, 2019
Jun. 30, 2019
Jun. 30, 2019
2019 Private Placement [Member]          
Class of Stock [Line Items]          
Purchase agreement, description         (i) 1 share of common stock and (ii) a warrant to purchase 1 share of common stock at an initial exercise price of $3.00 per share (the “2019 Warrants”).
Risk free interest rate       2.10% 2.40%
Expected stock price volatility       50.70% 50.60%
Expected life of options (years)       4 years 7 months 6 days 4 years 9 months 18 days
Expected dividend yield       0.00% 0.00%
Cash commission, percentage         8.00%
Exercise price, per share         $ 3.00
Common stock purchase price, per share         10.00%
Warrants exercisable, term         5 years
Units sold under private placement       388,200 2,292,179
Gross proceeds from private placement         $ 5,730,448
Estimated fair value of the broker warrants to be issued         $ 190,817
Broker warrants to be issued shares         193,417
Fair value of warrant issued       $ 261,950 $ 1,563,191
Direct offset to proceeds from the private placement       $ 117,393 929,821
Cash commissions amounting         641,654
Commission fees related to financing         $ 97,350
2019 Private Placement [Member] | Paulson [Member]          
Class of Stock [Line Items]          
Cash commission, percentage         12.00%
Warrants exercisable, term         5 years
Private placement transaction, description         HRA will receive a cash commission equal to 8% of the gross proceeds from the sale of the 2019 Units sold by HRA. In addition to the brokers' commission, the Company will issue 5-year warrants to HRA to purchase an amount of Common Stock equal to 8% of the total amount of Shares sold by HRA in the 2019 Private Placement at an exercise price of $3.00 per share.
2019 Private Placement [Member] | Warrant [Member]          
Class of Stock [Line Items]          
Maximum shares issuable under private placement         4,000,000
Maximum potential gross proceeds from financing         $ 10,000,000
Broker warrants exercise price to be issued       $ 2.50 $ 2.50
2019 Private Placement [Member] | Warrant [Member] | Minimum [Member]          
Class of Stock [Line Items]          
Broker warrants exercise price to be issued       2.75 2.75
2019 Private Placement [Member] | Warrant [Member] | Maximum [Member]          
Class of Stock [Line Items]          
Broker warrants exercise price to be issued       $ 3.00 $ 3.00
Private Placement [Member]          
Class of Stock [Line Items]          
Private placement transaction, description (i) 1 share of common stock and (ii) a warrant to purchase 1 share of common stock at an initial exercise price of $3.00 per share (the "2019 Warrants"), to the New Purchasers.        
2018 Private Placement [Member]          
Class of Stock [Line Items]          
Purchase agreement, description   (i) 1 share (each, a "Share") of common stock and (ii) a warrant to purchase 1 share of common stock at an initial exercise price of $3.00 per share (the "2018 Warrants").      
Risk free interest rate         2.90%
Expected stock price volatility         49.80%
Expected life of options (years)         4 years 7 months 6 days
Expected dividend yield         0.00%
Cash commission, percentage         8.00%
Exercise price, per share         $ 3.00
Warrants exercisable, term         5 years
Acquired percentage     10.00%    
Units sold under private placement       0 170,000
Gross proceeds from private placement $ 1,538,000        
Broker warrants to be issued shares         36,096
Fair value of warrant issued         $ 115,674
Private placement transaction, description     The Company and HRA agreed (i) to extend the Tail Period until June 30, 2019, (ii) to modify the HRA Fee so that HRA is entitled to receive a cash fee equal to 8% of the gross proceeds received by the Company from Prospects in all subsequent private placement transactions and (iii) to modify the HRA Warrants so that they are exercisable to purchase shares of Common Stock (or common stock equivalents) in an amount equal to 8% of the shares of Common Stock purchased by Prospects in subsequent private placements (collectively, the “HRA Amendments”). Upon issuance, the HRA Warrants will be immediately exercisable and expire five years from the closing of the related transaction.    
Shares issued under private placement 615,200        
Credit adjustment amount related to HRA commission       $ 18,052  
Adjustments of net expense         17,614
Legal costs related to private placement issuance costs         7,340
Brokerage commission         6,440
Commission liability       $ 3,834 $ 3,834
Percentage of cash commission and broker warrants         8.00%
2018 Private Placement [Member] | Warrant [Member]          
Class of Stock [Line Items]          
Broker warrants to be issued shares         244,073